Study Stopped
No funding
Negative Pressure Wound Therapy and Allogeneic Human Skin Grafts for Wound Bed Preparation
NPWTvsGPA
Comparative Study of Negative Pressure Wound Therapy and Allogeneic Human Skin Grafts for Wound Bed Preparation in Necrotising Soft Tissue Infections
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Introduction Necrotising soft tissue infections (NSTI) incorporate a spectrum of pathologies, all characterized by an infectious state, typically arising after a penetrating trauma or a surgical procedure and an expeditious spreading of necrosis throughout the soft tissues of the body. It is a rare, life-threatening and devastating infection defined by a necrosis of fascia, subcutaneous tissues and skin. Aggressive surgical debridement to remove all necrotic tissue and define the extent of the disease is still the mainstay of correct treatment of NSTI. Both negative pressure wound therapy (NPWT) and the application of allograft skin to debrided areas, are documented options for wound bed preparation which are standard in the university hospital of Gent. NPWT is a technique for wound bed preparation involving the controlled application of sub-atmospheric pressure to the local wound environment, using a sealed wound dressing connected to a vacuum pump. Mechanisms of action attributed to NPWT include an increase in blood flow, promotion of angiogenesis, reduction in wound surface area, positive modulation of the inhibitory contents of wound fluid, induction of cell proliferation, reduction of edema, and bacterial clearance. Allograft skin or cadaveric skin possesses many of the ideal properties of biologic dressings, and plays a major role in the surgical management of extensive wounds when autologous tissue may not be immediately available. It reduces evaporative water loss and the drainage of protein-rich fluids, prevents wound desiccation, and suppresses microbial proliferation. Wound pain is lessened and the allograft restores a physiologic barrier at the wound surface. Enhancing revascularization, and thereby creating a viable wound bed before final reconstruction, is perceived as one of the most important features of allografting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2013
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 30, 2013
CompletedStudy Start
First participant enrolled
October 1, 2013
CompletedFirst Posted
Study publicly available on registry
December 11, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedFebruary 10, 2023
February 1, 2023
2.7 years
September 30, 2013
February 7, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Quality of wound bed preparation until autografting.
WHAT software, clinical assessment by plastic surgeon, Laser Doppler Imaging scan.
After 3 days
Secondary Outcomes (3)
Pain assessment until autografting.
After 3 days
Ease of use until autografting.
After 3 days
Cost utility until autografting.
After 3 days
Study Arms (2)
negative pressure wound therapy (NPWT)
ACTIVE COMPARATORnegative pressure wound therapy (NPWT)
Glycerol Preserved Allografts (GPA)
ACTIVE COMPARATORGlycerol Preserved Allografts (GPA)
Interventions
NPWT changed twice a week.
GPA changed every 7 to 10 days.
Eligibility Criteria
You may qualify if:
- Necrotising soft tissue infection
You may not qualify if:
- None specific
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Ghent
Ghent, 9000, Belgium
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stan Monstrey, MD, PhD
University Hospital, Ghent
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 30, 2013
First Posted
December 11, 2014
Study Start
October 1, 2013
Primary Completion
June 1, 2016
Study Completion
October 1, 2016
Last Updated
February 10, 2023
Record last verified: 2023-02